Literature DB >> 19057918

A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions.

C Dirk Keene1, Rubens C Chang, James B Leverenz, Oleg Kopyov, Susan Perlman, Robert F Hevner, Donald E Born, Thomas D Bird, Thomas J Montine.   

Abstract

Transplantation of human fetal neural tissue into adult neostriatum is an experimental therapy for Huntington's disease (HD). Here we describe a patient with HD who received ten intrastriatal human fetal neural transplants and, at one site, an autologous sural nerve co-graft. Although initially clinically stable, she developed worsening asymmetric upper motor neuron symptoms in addition to progression of HD, and ultimately died 121 months post transplantation. Eight neural transplants, up to 2.9 cm, and three ependymal cysts, up to 2.0 cm, were identified. The autologous sural nerve co-graft was found adjacent to the largest mass lesion, which, along with the ependymal cyst, exhibited pronounced mass effect on the internal capsules bilaterally. Grafts were composed of neurons and glia embedded in disorganized neuropil; robust Y chromosome labeling was present in a subset of grafts and cysts. The graft-host border was discrete, and there was no evidence of graft rejection or HD pathologic changes within donor neurons. This report, for the first time, highlights the potential for graft overgrowth in a patient receiving fetal neural transplantation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19057918      PMCID: PMC2676786          DOI: 10.1007/s00401-008-0465-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  27 in total

1.  Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease.

Authors:  A Bachoud-Lévi; C Bourdet; P Brugières; J P Nguyen; T Grandmougin; B Haddad; R Jény; P Bartolomeo; M F Boissé; G D Barba; J D Degos; A M Ergis; J P Lefaucheur; F Lisovoski; E Pailhous; P Rémy; S Palfi; G L Defer; P Cesaro; P Hantraye; M Peschanski
Journal:  Exp Neurol       Date:  2000-01       Impact factor: 5.330

2.  Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475.

Authors:  A E Rosser; R A Barker; T Harrower; C Watts; M Farrington; A K Ho; R M Burnstein; D K Menon; J H Gillard; J Pickard; S B Dunnett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

3.  Stereotactic technique and pathophysiological mechanisms of neurotransplantation in Huntington's chorea.

Authors:  M Sramka; M Rattaj; H Molina; J Vojtassák; V Belan; E Ruzický
Journal:  Stereotact Funct Neurosurg       Date:  1992       Impact factor: 1.875

4.  Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology.

Authors:  T B Freeman; F Cicchetti; R A Hauser; T W Deacon; X J Li; S M Hersch; G M Nauert; P R Sanberg; J H Kordower; S Saporta; O Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

5.  Bilateral human fetal striatal transplantation in Huntington's disease.

Authors:  R A Hauser; S Furtado; C R Cimino; H Delgado; S Eichler; S Schwartz; D Scott; G M Nauert; E Soety; V Sossi; D A Holt; P R Sanberg; A J Stoessl; T B Freeman
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

6.  Motor and cognitive improvements in patients with Huntington's disease after neural transplantation.

Authors:  A C Bachoud-Lévi; P Rémy; J P Nguyen; P Brugières; J P Lefaucheur; C Bourdet; S Baudic; V Gaura; P Maison; B Haddad; M F Boissé; T Grandmougin; R Jény; P Bartolomeo; G Dalla Barba; J D Degos; F Lisovoski; A M Ergis; E Pailhous; P Cesaro; P Hantraye; M Peschanski
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

7.  Neuropathological classification of Huntington's disease.

Authors:  J P Vonsattel; R H Myers; T J Stevens; R J Ferrante; E D Bird; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1985-11       Impact factor: 3.685

8.  Peripheral nerve-dopamine neuron co-grafts in MPTP-treated monkeys: augmentation of tyrosine hydroxylase-positive fiber staining and dopamine content in host systems.

Authors:  T J Collier; J D Elsworth; J R Taylor; J R Sladek; R H Roth; D E Redmond
Journal:  Neuroscience       Date:  1994-08       Impact factor: 3.590

9.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.

Authors:  Jia-Yi Li; Elisabet Englund; Janice L Holton; Denis Soulet; Peter Hagell; Andrew J Lees; Tammaryn Lashley; Niall P Quinn; Stig Rehncrona; Anders Björklund; Håkan Widner; Tamas Revesz; Olle Lindvall; Patrik Brundin
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

10.  Intrastriatal cografts of autologous adrenal medulla and sural nerve in MPTP-induced parkinsonian macaques: behavioral and anatomical assessment.

Authors:  R L Watts; A S Mandir; R A Bakay
Journal:  Cell Transplant       Date:  1995 Jan-Feb       Impact factor: 4.139

View more
  30 in total

Review 1.  Experimental surgical therapies for Huntington's disease.

Authors:  Jelle Demeestere; Wim Vandenberghe
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

Review 2.  G-protein-coupled receptors in adult neurogenesis.

Authors:  Van A Doze; Dianne M Perez
Journal:  Pharmacol Rev       Date:  2012-05-18       Impact factor: 25.468

3.  On the origin of glioneural neoplasms after neural cell transplantation.

Authors:  Ninette Amariglio; Gideon Rechavi
Journal:  Nat Med       Date:  2010-02       Impact factor: 53.440

4.  Overexpression of basic helix-loop-helix transcription factors enhances neuronal differentiation of fetal human neural progenitor cells in various ways.

Authors:  Angéline Serre; Evan Y Snyder; Jacques Mallet; Delphine Buchet
Journal:  Stem Cells Dev       Date:  2011-07-18       Impact factor: 3.272

5.  Characterization of ectopic colonies that form in widespread areas of the nervous system with neural stem cell transplants into the site of a severe spinal cord injury.

Authors:  Oswald Steward; Kelli G Sharp; Kelly Matsudaira Yee; Maya N Hatch; Joseph F Bonner
Journal:  J Neurosci       Date:  2014-10-15       Impact factor: 6.167

Review 6.  Neural stem cells could serve as a therapeutic material for age-related neurodegenerative diseases.

Authors:  Sarawut Suksuphew; Parinya Noisa
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

Review 7.  Cell-based therapies for Huntington's disease.

Authors:  Yiju Chen; Richard L Carter; In K Cho; Anthony W S Chan
Journal:  Drug Discov Today       Date:  2014-03-12       Impact factor: 7.851

Review 8.  Current Perspective of Stem Cell Therapy in Neurodegenerative and Metabolic Diseases.

Authors:  Ajay Kumar; Karthikeyan Narayanan; Ravi Kumar Chaudhary; Sachin Mishra; Sundramurthy Kumar; Kumar Jayaseelan Vinoth; Parasuraman Padmanabhan; Balázs Gulyás
Journal:  Mol Neurobiol       Date:  2016-11-04       Impact factor: 5.590

9.  Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges.

Authors:  Camille Nicoleau; Pedro Viegas; Marc Peschanski; Anselme L Perrier
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 10.  Stem Cell Therapy for the Central Nervous System in Lysosomal Storage Diseases.

Authors:  Faez Siddiqi; John H Wolfe
Journal:  Hum Gene Ther       Date:  2016-07-13       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.